Zhousheng Yang

发表

Association of lncRNA PVT1 Gene Polymorphisms with the Risk of Essential Hypertension in Chinese Population

Meiling Zuo, X. Yu, Yuan-lin Xie, 2022, BioMed research international.

Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

Dafeng Yang, Sheng-Lan Tan, Pei Jiang, 2020, Journal of cellular and molecular medicine.

SOCS3 Gene Polymorphism and Hypertension Susceptibility in Chinese Population: A Two-Center Case-Control Study

Meiling Zuo, Yuan-lin Xie, Zhousheng Yang, 2021, BioMed research international.

Comprehensive expression profiles and bioinformatics analysis reveal special circular RNA expression and potential predictability in the peripheral blood of humans with idiopathic membranous nephropathy

D. Ye, Kun Ye, Yi-Yun Huang, 2019, Molecular medicine reports.

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway

Dafeng Yang, Qiong Lu, Sheng-Lan Tan, 2018, BioMed research international.

Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway

Zhousheng Yang, Lei Chen, Mingyu Meng, 2023, Mediators of inflammation.

Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis via regulating miR-21 in Human Cholangiocarcinoma Cells

Pei Jiang, Yang Deng, Yang-zhao Zhou, 2020, Journal of Cancer.

Research progress of sophoridine’s pharmacological activities and its molecular mechanism: an updated review

D. Ye, Chunxia Chen, Zhousheng Yang, 2023, Frontiers in pharmacology.

Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

Yang Deng, Lei Chen, Xin Li, 2021, Journal of Cancer.